Ponatinib in patients with refractory acute myeloid leukaemia: findings from a phase 1 study. (21st May 2013) - Shah, Neil P.; Talpaz, Moshe; Deininger, Michael W. N.; Mauro, Michael J.; Flinn, Ian W.; Bixby, Dale; Lustgarten, Stephanie; Gozgit, Joseph M.; Clackson, Tim; Turner, Christopher D.; Haluska, Frank G.; Kantarjian, Hagop; et al.